Product Information
TOLTERODINE TART ER 2 MG CAP is a generic product labeled by Mylan Pharmaceuticals Inc., priced at $0.2678 per EA under NDC 59762004702. Its NADAC has been published 555 times since Feb 17, 2016.
FDA first approved this application on Dec 22, 2000.
Strength
2 mg/1
Manufacturer
Mylan Pharmaceuticals Inc.NDC
59762004702
Classification
Generic
Dosage Form
CAPSULE, EXTENDED RELEASE
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
TOLTERODINE TARTRATEApproval Type
Authorized Generic (NDA)
FDA Application
NDA021228FDA Approved
12/22/2000
On Market Since
1/22/2016
Pharmacological Classes
Price Statistics
The NADAC for TOLTERODINE TART ER 2 MG CAP has been published 555 times since Feb 17, 2016, and over the history we have for it it has declined 93.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.2678 per EA |
|---|---|
| All-time high | $4.3685 (Apr 13, 2016) |
| All-time low | $0.2590 (Jul 22, 2026) |
| 52-week high | $0.3763 |
| 52-week low | $0.2590 |
| Median price | $1.4272 |
| Average price | $1.5526 |
| Largest weekly change | +65.6% (Aug 21, 2024) |
| Weeks tracked | 555 |
| Tracking since | Feb 17, 2016 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 1% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Mylan Pharmaceuticals Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
tolterodine tartrate market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Cholinergic Muscarinic Antagonist class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of TOLTERODINE TART ER 2 MG CAP?
The current National Average Drug Acquisition Cost (NADAC) for TOLTERODINE TART ER 2 MG CAP, manufactured by Mylan Pharmaceuticals Inc., is $0.2678 per EA (NDC 59762004702), effective Sep 30, 2026.
How has the price of TOLTERODINE TART ER 2 MG CAP changed over time?
Over the history we have for it, the NADAC for TOLTERODINE TART ER 2 MG CAP has declined 93.7%. It has been tracked across 555 weekly CMS publications since Feb 17, 2016.
What are the highest and lowest recorded NADAC prices for TOLTERODINE TART ER 2 MG CAP?
Since Feb 17, 2016, the NADAC for TOLTERODINE TART ER 2 MG CAP has ranged from a low of $0.2590 (Jul 22, 2026) to a high of $4.3685 (Apr 13, 2016), with a median of $1.4272 per EA.
Are there cheaper alternatives to TOLTERODINE TART ER 2 MG CAP?
Yes. 1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, TOLTERODINE TART ER 2 MG CAP, is $0.2648 per EA — about 1% below TOLTERODINE TART ER 2 MG CAP.
Who manufactures TOLTERODINE TART ER 2 MG CAP?
TOLTERODINE TART ER 2 MG CAP (NDC 59762004702) is labeled by Mylan Pharmaceuticals Inc., and CMS classifies it as a generic product.